This study reveals notable transcriptional changes in cholesterol biosynthesis and metabolism pathways following heart revascularization.Using RNA-seq data and pathway enrichment analysis, we identified key genes and biological processes associated with cholesterol homeostasis, providing insights into the molecular adaptations accompanying this therapeutic intervention.
Biological implications of cholesterol biosynthesis and metabolism
Table of Contents
- Biological implications of cholesterol biosynthesis and metabolism
- potential crosstalk between mitochondrial stress and lipid metabolism
- Clinical relevance of molecular findings
- Epigenetic regulation of cholesterol-related genes
- Comparison with previous studies
- Therapeutic implications and future directions
Cholesterol biosynthesis is essential for maintaining cell membrane integrity, intracellular signaling, and sterol homeostasis [9].Our analysis revealed significant enrichment of pathways such as the “Cholesterol Biosynthesis Pathway in Hepatocytes” and biological processes like “Regulation of Cholesterol Biosynthesis.” These findings suggest that heart revascularization induces activation of cholesterol production, possibly to support cellular repair and regeneration in ischemic tissues. Downregulation of EBP, a critical enzyme in sterol biosynthesis, underscores the importance of sterol intermediates in post-revascularization recovery [13].
Additionally, the downregulation of ABCG1, a key regulator of cholesterol efflux, indicates enhanced lipid transport and efflux mechanisms. This is consistent with prior studies showing that ABCG1 protects against cholesterol accumulation by promoting its removal from cells [12]. The simultaneous activation of cholesterol biosynthesis and efflux suggests a dynamic regulation of lipid metabolism to meet the physiological demands of recovery.
potential crosstalk between mitochondrial stress and lipid metabolism
The observed upregulation of PINK1, a key regulator of mitochondrial quality control, suggests a potential interplay between mitochondrial dynamics and lipid metabolism. Mitochondrial dysfunction is known to influence cholesterol biosynthesis and efflux pathways [16], likely through altered energy availability and reactive oxygen species (ROS) signaling. These findings align with previous studies linking mitochondrial stress responses to lipid remodeling during cardiovascular recovery, highlighting the need to further explore this crosstalk in therapeutic interventions.
Clinical relevance of molecular findings
The strong correlations between gene expression changes and clinical lipid parameters provide compelling evidence for the functional meaning of our transcriptomic findings. The negative correlation between ABCG1 expression and triglyceride levels (r = − 0.89) is especially noteworthy, as it suggests that downregulation of this cholesterol efflux transporter directly contributes to altered lipid homeostasis in post-revascularization patients.
Similarly, the positive correlations between EBP expression and both LDL and total cholesterol levels establish a direct link between reduced cholesterol biosynthetic capacity and circulating cholesterol profiles. These findings suggest that the coordinated downregulation of cholesterol metabolism genes we observed represents a functionally relevant metabolic adaptation rather than incidental transcriptional noise.
the involvement of PINK1 in correlations with metabolic markers (BMI and HbA1c) supports our hypothesis of crosstalk between mitochondrial stress responses and lipid metabolism, suggesting that post-revascularization metabolic reprogramming extends beyond cholesterol pathways to encompass broader cellular energetics.
The inclusion of chromatin regulators such as BEND3 and CDYL in the differentially expressed genes suggests an epigenetic layer of control over cholesterol metabolism. BEND3 is known to regulate transcriptional repression, while CDYL modulates histone acetylation [17]. These findings imply that revascularization-induced metabolic changes may be partially orchestrated through epigenetic modifications, enabling cells to rapidly adapt their transcriptional programs.
Comparison with previous studies
Our findings align with prior research showing that cholesterol biosynthesis pathways are critical for cardiovascular recovery and adaptation [11]. However, the identification of novel players, such as LPCAT3, involved in lipid remodeling, provides additional insights into how membrane lipid composition might be regulated during recovery [14]. This complements existing evidence linking lipid remodeling to cellular adaptation under stress conditions.
Therapeutic implications and future directions
The downregulation of ABCG1, which is invol